| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |